A study to learn more about breast cancer that has spread to the brain (PRIMROSE study)
This study wants to find out more about breast cancer that has spread to the brain (secondary brain cancer).
Salford
Available
A study looking at additional radiotherapy for glioblastoma before surgery to improve the outcome of treatment (POBIG)
This study is looking at having a single dose of radiotherapy targeting glioblastoma before surgery.
A trial looking at different combinations of treatment for newly diagnosed myeloma (RADAR, Myeloma XV)
This trial is looking at bone marrow samples to help work out the best treatment for myeloma.
A study using Cytosponge to find Barrett’s oesophagus and early oesophageal cancer (DELTA)
This study is using the Cytosponge test to identify who might have a higher risk of developing Barrett’s oesophagus and oesophageal cancer.
A study of tissue and blood samples to learn more about glioma (Tessa Jowell BRAIN MATRIX)
This study is collecting blood and tissue samples from people who have a glioma.
A study to find out more about mesothelioma (Meso-ORIGINS)
This study is to learn more about mesothelioma and how it develops after exposure to asbestos.
A trial of venetoclax with low dose cytarabine for acute myeloid leukaemia (VICTOR)
This trial is comparing venetoclax and low dose cytarabine with intensive chemotherapy. It is for people with acute myeloid leukaemia aged 55 years and older.
A trial of ixazomib, lenalidomide and dexamethasone for people with myeloma (FITNEsS)
This trial is for people who might not be able to have the full dose of treatment because they have other illnesses or are not fit enough.
A study to find out whether a PET-CT scan can help to tell who needs to have rituximab or obinutuzumab after the initial treatment for lymphoma (PETReA)
This study is for people with follicular lymphoma who are going to have treatment that reaches their whole body (systemic treatment) for the first time.
A study looking at a new test called FIT to look for signs of bowel cancer (NICE FIT)
A study to see if the faecal immunohistochemistry test (FIT) can tell who needs to have a bowel test (colonoscopy) to check for bowel cancer.